![](/img/cover-not-exists.png)
LB21. Preemptive Therapy (PET) vs. Prophylaxis for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Donor Seropositive/Recipient Seronegative (D+R−) Liver Transplant Recipients (LTR): A NIH-Sponsored, Randomized, Controlled, Multicenter Trial
Singh, Nina, Winston, Drew, Razonable, Raymund R, Lyon III, G Marshall, Silveira, Fernanda P, Wagener, Marilyn, Limaye, Ajit PVolume:
5
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofy229.2195
Date:
November, 2018
File:
PDF, 343 KB
2018